Henry Schein, Inc. HSIC
86.37
0.84
0.98%
as of 25 Sep
- Market cap
- $9.5B
- P/E
- 25.0×
Follow HSIC
Indexes
indicate stock being part of an index,
Insider Buys
alert about insiders buying in the last 12 month
Henry Schein, Inc. (HSIC) Revenue growth
Henry Schein, Inc.'s revenue growth over the twelve months to 30 June 2026 was 6.49%, up 2.5 percentage points from fiscal 2025 (4.03%). Over the past ten years it has ranged from −23.2% (fiscal 2017) to 22.6% (fiscal 2021); the current reading is higher than 64% of that period. That is below the Medical Distribution industry median of 11.5% and below the Healthcare sector median of 8.26%.
Revenue growth, annual
Annual
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | 4.03% | 1.32 |
| FY2024 | 2.71% | 5.15 |
| FY2023 | −2.44% | (4.42) |
| FY2022 | 1.98% | (20.57) |
| FY2021 | 22.6% | 21.22 |
| FY2020 | 1.33% | (4.70) |
| FY2019 | 6.03% | 0.02 |
| FY2018 | 6.01% | 29.24 |
| FY2017 | −23.2% | (32.09) |
| FY2016 | 8.86% | 6.37 |
Quarterly
| Period | Revenue growth | Change (points) |
|---|---|---|
| Jun 2026 | 6.73% | 0.42 |
| Mar 2026 | 6.31% | (1.40) |
| Dec 2025 | 7.71% | 2.51 |
| Sep 2025 | 5.20% | 1.88 |
| 42 more quarters | Free account |
Against its own ten years
Low −23.2%
High 22.6%
Ten-year median
2.71%
Current reading's percentile
64
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| ACH Accendra Health, Inc. compare | 247.0% |
| AHG Akso Health Group Sponsored ADR compare | 208.4% |
| COSM Cosmos Health Inc. compare | 33.8% |
| FOCL FocalTherics compare | 29.5% |
| CAH Cardinal Health, Inc. compare | 14.2% |
| MCK McKesson Corporation compare | 8.84% |
| HSIC Henry Schein, Inc. | 6.49% |
| COR Cencora, Inc. compare | 5.09% |
| YI 111, Inc. Sponsored ADR compare | −16.2% |
| Medical Distribution industry median | 11.5% |
| Healthcare sector median | 8.26% |
| Market median | 7.41% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on HSIC
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- The full statement